AKBA FY 2018 Earnings — Akebia Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AKBAAkebia Therapeutics, Inc.

$366M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$208M+16.7% YoY

Gross Profit

$200M96.3% margin

Operating Income

-$178M-85.8% margin

Net Income

-$172M-82.7% margin

EPS (Diluted)

$-1.47

Cash Flow

Operating Cash Flow

-$97M

Free Cash Flow

-$99M

Stock-Based Comp.

$19M

Balance Sheet

Total Assets

$997M

Total Liabilities

$361M

Stockholders' Equity

$636M

Cash & Equivalents

$105M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$208M	$178M	+16.7%
Gross Profit	$200M	$177M	+12.8%
Operating Income	-$178M	-$80M	-122.9%
Net Income	-$172M	-$77M	-123.5%